Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
1988-4-11
|
| pubmed:abstractText |
In order to examine the in vivo activity of BMY-28100, serial quantitative nasal cultures were taken from 52 nasal carriers of Staphylococcus aureus following administration of the antimicrobial. Nasal carriage rates and mean log titers decreased significantly during (days 2-4 and 5-8) and following (days 1-2 and 6-7) treatment. No change in antibiotic sensitivities was noted in follow-up isolates, and the MIC90 remained at 2mcg/ml. BMY-28100 demonstrated good in vivo activity against Staphylococcus aureus.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Dec
|
| pubmed:issn |
0722-2211
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
6
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
679-81
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:3440459-Adult,
pubmed-meshheading:3440459-Carrier State,
pubmed-meshheading:3440459-Cephalosporins,
pubmed-meshheading:3440459-Humans,
pubmed-meshheading:3440459-Male,
pubmed-meshheading:3440459-Nasal Cavity,
pubmed-meshheading:3440459-Staphylococcal Infections,
pubmed-meshheading:3440459-Staphylococcus aureus
|
| pubmed:year |
1987
|
| pubmed:articleTitle |
Effect of BMY-28100, a new cephalosporin, on Staphylococcus aureus nasal carriage.
|
| pubmed:affiliation |
Department of Medicine, Baylor College of Medicine, Houston, Texas 77030.
|
| pubmed:publicationType |
Journal Article
|